Christoph Schramm, Michael Bubenheim, René Adam, Vincent Karam, John Buckels, John G. O'Grady, Neville Jamieson, Stephen Pollard, Peter Neuhaus, Michael M. Manns, Robert Porte, Denis Castaing, Andreas Paul, Oscar Traynor, James Garden, Styrbjörn Friman, Bo‐Goran Ericzon, Lutz Fischer, Stefan Vitko, Marek Krawczyk, Herold J. Metselaar, Aksel Foss, Murat Kilic, Keith Rolles, Patrizia Burra, Xavier Rogiers, Ansgar W.

James Neuberger – 15 January 2010

Walid Mohamed El Moghazy, Yasuhiro Ogura, Kouji Harada, Akio Koizumi, Shinji Uemoto – 15 January 2010 – Several studies have shown improved growth after liver transplantation, but long‐term follow‐up data have been lacking. This study was aimed at evaluating the ability of children to catch up in height after living donor liver transplantation (LDLT) and at clarifying factors affecting growth. Growth was assessed by serial height measurements performed during follow‐up.

Vinod K. Audimoolam, Mathew R. Foxton, Kosh Agarwal, John G. O'Grady, Michael A. Heneghan – 15 January 2010

Kate R. Muller, Robert Padbury, Gary P. Jeffrey, Nicola K. Poplawski, Philip Thompson, Anne Tonkin, Hugh A. J. Harley – 15 January 2010 – Transthyretin amyloid polyneuropathy, caused by mutations in the transthyretin gene, is a progressive condition for which liver transplantation is an established treatment. Favorable outcomes have been described in patients with the most common transthyretin mutation, Val30Met, but outcomes have been variable in patients with other mutations.

Toshimi Kaido, Yasutsugu Takada, Shinji Uemoto – 15 January 2010

Sophie Dupuis‐Girod, Anne‐Laure Chesnais, Isabelle Ginon, Jérôme Dumortier, Jean‐Christophe Saurin, Gérard Finet, Evelyne Decullier, Denis Marion, Henri Plauchu, Olivier Boillot – 12 January 2010 – Hepatic involvement occurs in up to 74% of patients with hereditary hemorrhagic telangiectasia (HHT) and is characterized by a spectrum of arteriovenous malformations. Three different types of intrahepatic shunting may be present: hepatic artery to hepatic veins, hepatic artery to portal vein, and portal vein to hepatic vein.

Frédéric Bert, Beatrice Larroque, Catherine Paugam‐Burtz, Sylvie Janny, Francois Durand, Fédérica Dondero, Dominique‐Charles Valla, Jacques Belghiti, Richard Moreau, Marie‐Hélène Nicolas‐Chanoine – 12 January 2010 – Bloodstream infections (BSIs) are a major cause of mortality in liver transplant recipients. The incidence, microbiology, and outcome of BSIs in the first year after liver transplantation were analyzed in 704 patients who underwent transplantation at a single center between 1997 and 2007. BSIs occurred in 205 (29.1%) of the 704 patients.

Ana‐Paula Barreiros, Felix Post, Maria Hoppe‐Lotichius, Reinhold P. Linke, Christian F. Vahl, Hans‐Joachim Schäfers, Peter R. Galle, Gerd Otto – 12 January 2010 – Liver transplantation (LT) is the only curative option for patients with familial amyloid polyneuropathy (FAP) at present. Twenty patients with FAP underwent LT between May 1998 and June 2007. Transthyretin mutations included predominantly the Val30Met mutation but also 10 other mutations.

See Ching Chan, Chung Mau Lo, Sheung Tat Fan – 12 January 2010